These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31111400)

  • 1. Network Patterns of Beta-Amyloid Deposition in Parkinson's Disease.
    Kim J; Ghadery C; Cho SS; Mihaescu A; Christopher L; Valli M; Houle S; Strafella AP
    Mol Neurobiol; 2019 Nov; 56(11):7731-7740. PubMed ID: 31111400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
    Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
    Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Aβ brain networks in Alzheimer's disease and healthy controls.
    Duan H; Jiang J; Xu J; Zhou H; Huang Z; Yu Z; Yan Z;
    Brain Res; 2017 Jan; 1655():77-89. PubMed ID: 27867033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin, β-amyloid, and cognition in Parkinson disease.
    Kotagal V; Spino C; Bohnen NI; Koeppe R; Albin RL
    Ann Neurol; 2018 May; 83(5):994-1002. PubMed ID: 29665066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.
    Ghadery C; Koshimori Y; Christopher L; Kim J; Rusjan P; Lang AE; Houle S; Strafella AP
    Mol Neurobiol; 2020 Jan; 57(1):492-501. PubMed ID: 31385228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
    Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
    Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.
    Schultz AP; Chhatwal JP; Hedden T; Mormino EC; Hanseeuw BJ; Sepulcre J; Huijbers W; LaPoint M; Buckley RF; Johnson KA; Sperling RA
    J Neurosci; 2017 Apr; 37(16):4323-4331. PubMed ID: 28314821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
    Villemagne VL; Ataka S; Mizuno T; Brooks WS; Wada Y; Kondo M; Jones G; Watanabe Y; Mulligan R; Nakagawa M; Miki T; Shimada H; O'Keefe GJ; Masters CL; Mori H; Rowe CC
    Arch Neurol; 2009 Dec; 66(12):1537-44. PubMed ID: 20008660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.
    Hatsuta H; Takao M; Ishii K; Ishiwata K; Saito Y; Kanemaru K; Arai T; Suhara T; Shimada H; Shinotoh H; Tamaoka A; Murayama S
    Curr Alzheimer Res; 2015; 12(3):278-86. PubMed ID: 25731622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
    Mori T; Shimada H; Shinotoh H; Hirano S; Eguchi Y; Yamada M; Fukuhara R; Tanimukai S; Zhang MR; Kuwabara S; Ueno S; Suhara T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):449-55. PubMed ID: 24133289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of amyloid-β peptide functional brain networks in AD, MCI and HC.
    Jiang J; Duan H; Huang Z; Yu Z;
    Biomed Mater Eng; 2015; 26 Suppl 1():S2197-205. PubMed ID: 26405999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.